REFERENCES
- Kasick DP, McKnight CA, Klisovic E. “Bath Salt” ingestion leading to severe intoxication delirium: Two cases and a brief review of the emergence of mephedrone use. Am J Drug Alcohol Abuse 2012; e-pub. Last accessed on January 10, 2012.
- Penders T, Gestring R. Hallucinatory delirium following the use of MDPV: “Bath Salts”. Gen Hosp Psychiatry 2011; 33(5): 525–526.
- Spiller HA, Ryan ML, Weston RG, . Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol 2011; 49:499–505.
- Centers for Disease Control and Prevention (CDC). Emergency department visits after use of a drug sold as “Bath Salts” – Michigan, November 13, 2010 – March 31, 2011. Morb Mortal Wkly Rep 2011; 60(19):624–627.
- Antonowicz JL, Metzger AK, Ramanujam SL. Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: Two cases. Gen Hosp Psychiatry 2011; 33(6): 640.e5–646.e5.
- Ross EA, Watson M, Goldberger B. “Bath Salts” intoxication. N Eng J Med 2011; 365:967–968.
- American Association of Poison Control Centers. “Bath Salts” data. AAPCC web site. Available at http://www.aapcc.org/dnn/Portals/0/Bath%20Salts%20Data%20for%20Website%201.5.2012.pdf. Last accessed on January 11, 2012.
- Schifano F, Albanese A, Fergus S, Mephedrone (4-methylmethcathinone; ‘meow-meow’); Chemical, pharmacological and clinical issues. Psychopharmacology 2011; 214:593–602.
- Coppola M, Mondola R. 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 2012; 208:12–15.
- Macher A, Kuftinec V, Penders T. False positive phencyclidine immunoassay results caused by methylenedioxypyrovalerone ( Manuscript in preparation).
- Roth D, Alarcon F, Fernandez JA, Acute rhabdomyolysis associated with cocaine intoxication. N Eng J Med 1988; 319:673–677.
- Rutterber AJ, McAnally HB, Wetli CV. Cocaine-associated rhabdomyolysis and excited delirium: Different stages of the same syndrome. Am J For Med Pathol 1999; 20(2):120–127.
- Lahmeyer HW. Phencyclidine intoxication, Physical restraint and acute renal failure. J Clin Psychiatry 1983; 44(11):430.
- Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 1992; 340:384–387.
- Richards JR, Johnson EB, Stark RW, Methamphetamine abuse and rhabdomyolysis in the ED: A 5-year study. Am J Emerg Med 1999; 17(7):681–685.
- Miladi A. Rhabdomyolysis associated with bupropion use as a smoking cessation adjunct: Review of the literature. Mil Med 2008; 173(10):1042–1043.
- Vilke GM, Debard ML, Chan TC, Excited delirium syndrome (ExDS): Defining based on a review of the literature. J Emerg Med 2011. e-pub.
- Redwood Toxicology Laboratory, Santa Rosa, CA. Available at http://www.redwoodtoxicology.com
- Drug Enforcement Administration, US Department of Justice. Schedules of controlled substances: Temporary placement of three synthetic cathinones in Schedule 1. Final Order. Fed Regist 2011; 76(204):65371–65375.
- De Paoli G, Maskell PD, Pounder DJ. Naphyrone: Analytical profile of the new “legal high” substitute for mephedrone. J Forensic Leg Med 2011; 18(2):93.